Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis

Bibliographic Details
Main Authors:	Farrugia, M, Kennett, R, Hilton-Jones, D, Newsom-Davis, J, Vincent, A
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
by: Farrugia, M, et al.
Published: (2007)

Myasthenia gravis with MuSK antibodies
by: Farrugia, M, et al.
Published: (2005)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
by: Farrugia, M, et al.
Published: (2006)

Facial muscle atrophy in musk antibody positive myasthenia gravis
by: Farrugia, M, et al.
Published: (2006)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
by: McConville, J, et al.
Published: (2004)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
by: Newsom-Davis, J, et al.
Published: (2001)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
by: Koneczny, I, et al.
Published: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
by: Koneczny, I, et al.
Published: (2014)

Potential mechanisms in MuSK-myasthenia gravis
by: Koneczny, I
Published: (2014)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
by: Vincent, A, et al.
Published: (2006)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
by: Lee, J, et al.
Published: (2006)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
by: Hoch, W, et al.
Published: (2001)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
by: Carmelo Rodolico, et al.
Published: (2020-07-01)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
by: Bennett, D, et al.
Published: (2006)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
by: Diana Epure, et al.
Published: (2016-06-01)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
by: Ting LI, et al.
Published: (2020-01-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
by: Yung-Chuan Huang, et al.
Published: (2008-07-01)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
by: Chang, T, et al.
Published: (2009)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
by: Yeh, J, et al.
Published: (2004)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
by: Cao, M
Published: (2021)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
by: Amber Eker, et al.
Published: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
by: Zunwei Zhang, et al.
Published: (2020-10-01)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
by: Phillips, W, et al.
Published: (2015)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
by: Shiraishi, H, et al.
Published: (2005)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
by: Christiane Schneider-Gold, et al.
Published: (2017-10-01)

Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
by: Farrugia, M, et al.
Published: (2007)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
by: Lee, J, et al.
Published: (2016)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
by: Aigli G. Vakrakou, et al.
Published: (2023-07-01)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
by: Vuslat Yilmaz, et al.
Published: (2015-01-01)

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
by: Shan CAO, et al.
Published: (2019-02-01)

MuSK Myasthenia Gravis—Potential Pathomechanisms and Treatment Directed against Specific Targets
by: Edyta Dziadkowiak, et al.
Published: (2024-03-01)

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
by: Niks, E, et al.
Published: (2006)

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
by: Leite, M, et al.
Published: (2005)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
by: McConville, J, et al.
Published: (2002)

MuSK Myasthenia Gravis in an HIV-infected Chinese old man successfully treated with pyridostigmine
by: Yirui Xie, et al.
Published: (2020-09-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
by: Deymeer, F, et al.
Published: (2007)

Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
by: Farrugia, M, et al.
Published: (2006)

MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
by: Benveniste, O, et al.
Published: (2005)

Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis
by: Umberto Basile, et al.
Published: (2021-08-01)

Grave prognosis of the musclespecific kinase (MuSK)-positive myasthenia gravis (MG): A false prejudice
by: Fu Liong Hiew
Published: (2020-01-01)